You are in:Home/Publications/Percutaneous radiofrequency ablation compared with surgical resection in the treatment of early hepatocellular carcinoma

Prof. Ashraf Mahmoud Abdelkader Mohamed :: Publications:

Title:
Percutaneous radiofrequency ablation compared with surgical resection in the treatment of early hepatocellular carcinoma
Authors: Ashraf M. Abd El-Kadera, Hazem E. Alia, Magdy A. Gadb,Badawy A. Abdel Azizb, Sharaf Elsayed Ali Hassanienb, Ali Hasaneenc,Ramy A. Mitwallyc
Year: 2017
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: Local
Paper Link: Not Available
Full paper Ashraf Mahmoud Abdelkader_HCC PUBLISHED.pdf
Supplementary materials Not Available
Abstract:

Objective The primary objective of this study was to compare between liver resection (LR) and radiofrequency ablation (RFA) in the management of early hepatocellular carcinoma (HCC). We are trying to provide an update that can be valuable in clinical practice for determining the most suitable first-line management option for early HCC. Patients and methods The study included 80 patients with earlyHCCaccording to the Barcelona Clinic Liver Cancer staging system. Patients were divided into two groups: group A included 40 (50%) patients treated through LR, whereas group B included 40 (50%) patients managedthroughpercutaneousRFA. In this study,weusedthe alternationmethodas an allocation process in this study.Procedures in both groupswere done according to conventional principles. Percutaneous RFA technique was done under the guidance of ultrasonography (US) in complete aseptic conditions. Collected data included procedure time, intraoperative bleeding, postoperative complications, pain score, ICU, and the total hospital stay days. After procedures, patientsweremonitored every three months throughout the follow-up period. Results A total of 80 patients with early HCC underwent treatment with LR (N=40) and with RFA (N=40). There is a significant difference between both groups regarding the mean time of the procedure: 145±19.8 versus 40.6±7.8 min for LR and RFA, respectively. Rates of recurrence significantly (P0.05) between LR and RFA groups. However, the recurrence percentage was slightly higher among patients treated by RFA compared with LR group. Conclusion Our prospective comparative study offers evidence that RFA provides a novel treatment for early HCC, and it shows survival and tumor relapse rates comparable to LR.

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus